Copyright
©The Author(s) 2024.
World J Clin Cases. May 16, 2024; 12(14): 2342-2349
Published online May 16, 2024. doi: 10.12998/wjcc.v12.i14.2342
Published online May 16, 2024. doi: 10.12998/wjcc.v12.i14.2342
Figure 1 Schematic diagram of the retrospective study design.
1st EGD: First esophagogastroduodenoscopy three years prior to diagnosis of gastric cancer (GC); 2nd EGD: Second esophagogastroduodenoscopy, GC diagnosed at that time.
Figure 2 Kyoto classification score at the time of onset of gastric cancer and three years before onset of gastric cancer.
Data are medians with interquartile ranges. aWilcoxon signed-rank test; bWilcoxon rank-sum test. GC: Gastric cancer; GA: Gastritis.
Figure 3 Modified atrophy score at the time of onset of gastric cancer and three years before onset of gastric cancer.
aWilcoxon signed-rank test; bWilcoxon rank-sum test. GC: Gastric cancer; GA: Gastritis.
- Citation: Suzuki Y, Katayama Y, Fujimoto Y, Kobori I, Tamano M. Non-improvement of atrophic gastritis in cases of gastric cancer after successful Helicobacter pylori eradication therapy. World J Clin Cases 2024; 12(14): 2342-2349
- URL: https://www.wjgnet.com/2307-8960/full/v12/i14/2342.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i14.2342